Articles related to Oncology, Medical

Early detection remains paramount – 90% of early-stage colon cancer patients survive at least 5 years after diagnosis, emphasizing the critical importance of timely screening.

Recent studies suggest that ultra-processed foods may raise cancer risk by up to 10% for pancreatic, colorectal, and breast cancers, highlighting the importance of dietary considerations in cancer prevention.

The inavolisib-based regimen more than doubled progression-free survival in PIK3CA-mutated breast cancers, offering a new standard of care for this challenging patient population.

In the BLUE-C trial, Cologuard Plus demonstrated a 93.9% sensitivity for colorectal cancer detection, significantly outperforming the 67.3% sensitivity of FIT.

The study’s findings highlight the complex interplay between CAR T cell therapy and cytokine signaling in AML treatment, suggesting new avenues for improving outcomes in this challenging disease.

AI-assisted diagnosis of lung cancer showed 87% sensitivity and 87% specificity in a meta-analysis, suggesting potential for improved accuracy in interpreting chest CT scans.